Fig. 2

LDL cholesterol goals and cut points for therapeutic lifestyle changes and drug therapy in different risk categories. *Of the 9,846 study subjects evaluated in the analysis, 1486 subjects with cardiovascular disease were excluded from the calculation of the Framingham score. Consequently, the Framingham score was calculated for 8360 subjects.